Gujarat Terce Laboratories Limited (GUJTERC.BO)
INR 59.97
(2.32%)
INR 59.97
(2.32%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 232.73 Million INR | -18.97% |
| 2022 | 287.22 Million INR | 4.22% |
| 2021 | 275.59 Million INR | 26.4% |
| 2020 | 218.03 Million INR | -3.12% |
| 2019 | 225.06 Million INR | 15.69% |
| 2018 | 194.53 Million INR | -0.29% |
| 2017 | 195.11 Million INR | -17.52% |
| 2016 | 236.55 Million INR | -3.43% |
| 2015 | 244.94 Million INR | -6.87% |
| 2014 | 263 Million INR | 1.45% |
| 2013 | 259.23 Million INR | 1.93% |
| 2012 | 254.33 Million INR | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 Q4 | - INR | -100.0% |
| 2023 Q1 | 287.22 Million INR | 0.0% |
| 2023 Q2 | - INR | -100.0% |
| 2023 Q3 | 254.61 Million INR | 0.0% |
| 2023 FY | 232.73 Million INR | -18.97% |
| 2022 Q4 | - INR | -100.0% |
| 2022 FY | 287.22 Million INR | 4.22% |
| 2022 Q1 | 275.59 Million INR | 0.0% |
| 2022 Q2 | - INR | -100.0% |
| 2022 Q3 | 275.66 Million INR | 0.0% |
| 2021 Q1 | 218.03 Million INR | 0.0% |
| 2021 FY | 275.59 Million INR | 26.4% |
| 2021 Q2 | - INR | -100.0% |
| 2021 Q3 | 251.29 Million INR | 0.0% |
| 2021 Q4 | - INR | -100.0% |
| 2020 FY | 218.03 Million INR | -3.12% |
| 2020 Q4 | - INR | -100.0% |
| 2020 Q3 | 223.38 Million INR | 0.0% |
| 2020 Q2 | - INR | -100.0% |
| 2020 Q1 | 225.06 Million INR | 0.0% |
| 2019 Q2 | - INR | -100.0% |
| 2019 Q1 | 193.37 Million INR | 0.0% |
| 2019 FY | 225.06 Million INR | 15.69% |
| 2019 Q4 | - INR | -100.0% |
| 2019 Q3 | 223.29 Million INR | 0.0% |
| 2018 Q2 | - INR | -100.0% |
| 2018 Q1 | 194.66 Million INR | 0.0% |
| 2018 FY | 194.53 Million INR | -0.29% |
| 2018 Q3 | 203.37 Million INR | 0.0% |
| 2018 Q4 | - INR | -100.0% |
| 2017 FY | 195.11 Million INR | -17.52% |
| 2017 Q1 | 236.55 Million INR | 0.0% |
| 2017 Q2 | - INR | -100.0% |
| 2017 Q3 | 174.75 Million INR | 0.0% |
| 2016 Q3 | 247.23 Million INR | 0.0% |
| 2016 Q1 | 244.68 Million INR | 0.0% |
| 2016 Q4 | - INR | -100.0% |
| 2016 FY | 236.55 Million INR | -3.43% |
| 2015 Q1 | 263 Million INR | 0.0% |
| 2015 FY | 244.94 Million INR | -6.87% |
| 2015 Q4 | - INR | -100.0% |
| 2015 Q2 | - INR | -100.0% |
| 2015 Q3 | 243.2 Million INR | 0.0% |
| 2014 Q3 | 186.86 Million INR | 0.0% |
| 2014 Q4 | - INR | -100.0% |
| 2014 FY | 263 Million INR | 1.45% |
| 2014 Q1 | 259.23 Million INR | 0.0% |
| 2014 Q2 | - INR | -100.0% |
| 2013 Q1 | 253.01 Million INR | 0.0% |
| 2013 FY | 259.23 Million INR | 1.93% |
| 2013 Q2 | - INR | -100.0% |
| 2013 Q4 | - INR | -100.0% |
| 2013 Q3 | 273.94 Million INR | 0.0% |
| 2012 FY | 254.33 Million INR | 0.0% |
| 2012 Q3 | 385.97 Million INR | 0.0% |
| 2010 Q1 | 134.18 Million INR | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| ANG Lifesciences India Limited | 2.42 Billion INR | 90.4% |
| Add-Shop E-Retail Limited | 1.25 Billion INR | 81.522% |
| Bacil Pharma Limited | 13.26 Million INR | -1655.034% |
| BDH Industries Limited | 934.11 Million INR | 75.085% |
| Beryl Drugs Limited | 174.86 Million INR | -33.091% |
| Cian Healthcare Limited | 1.61 Billion INR | 85.56% |
| Chemo Pharma Laboratories Limited | 130.15 Million INR | -78.818% |
| Colinz Laboratories Limited | 113.59 Million INR | -104.883% |
| Concord Drugs Limited | 588.06 Million INR | 60.424% |
| Deccan Health Care Limited | 1.08 Billion INR | 78.46% |
| DECIPHER LABS LIMITED | 336.33 Million INR | 30.802% |
| Denis Chem Lab Limited | 1.09 Billion INR | 78.716% |
| Gujarat Themis Biosyn Limited | 2.21 Billion INR | 89.474% |
| Hindustan Bio Sciences Limited | 33.74 Million INR | -589.728% |
| Kwality Pharmaceuticals Limited | 3.94 Billion INR | 94.096% |
| Makers Laboratories Limited | 1.61 Billion INR | 85.567% |
| Ishita Drugs and Industries Limited | 108.08 Million INR | -115.322% |
| Jenburkt Pharmaceuticals Limited | 1.65 Billion INR | 85.903% |
| KIMIA BIOSCIENCES LIMITED | 999.66 Million INR | 76.719% |
| Medi-Caps Limited | 1.27 Billion INR | 81.715% |
| MedPlus Health Services Limited | 30.04 Billion INR | 99.225% |
| Panchsheel Organics Limited | 1.59 Billion INR | 85.368% |
| Parmax Pharma Limited | 176.12 Million INR | -32.141% |
| Parnax Lab Limited | 1.88 Billion INR | 87.671% |
| Patidar Buildcon Limited | 94.27 Million INR | -146.866% |
| Sastasundar Ventures Limited | 11.49 Billion INR | 97.976% |
| SHAMROCK INDUSTRIAL CO.LTD. | 17.6 Million INR | -1222.283% |
| Smruthi Organics Limited | 1.18 Billion INR | 80.309% |
| Source Natural Foods and Herbal Supplements Limited | 236.5 Million INR | 1.595% |
| SUDARSHAN PHARMA INDUSTRIES LI | 2.83 Billion INR | 91.78% |
| Trident Lifeline Limited | 870.76 Million INR | 73.272% |
| Transchem Limited | 763.18 Million INR | 69.505% |
| Trinity League India Limited | 32.38 Million INR | -618.628% |
| Tyche Industries Limited | 1.36 Billion INR | 83.0% |
| Vikram Thermo (India) Limited | 1.42 Billion INR | 83.688% |
| Vista Pharmaceuticals Limited | 579.79 Million INR | 59.859% |
| Vivanza Biosciences Limited | 195.01 Million INR | -19.343% |
| Zenith Healthcare Limited | 97.41 Million INR | -138.916% |
| Zenlabs Ethica Limited | 402.58 Million INR | 42.19% |
| Phaarmasia Limited | 314.47 Million INR | 25.993% |
| PRAVEG LIMITED | 3.64 Billion INR | 93.617% |
| Sunil Healthcare Limited | 1.58 Billion INR | 85.316% |
| Syschem (India) Limited | 1.64 Billion INR | 85.811% |
| Sanjivani Paranteral Limited. | 434.05 Million INR | 46.381% |
| Mercury Laboratories Limited | 679.57 Million INR | 65.753% |
| SHELTER PHARMA LIMITED | 379.14 Million INR | 38.616% |
| Vasundhara Rasayans Limited | 373.03 Million INR | 37.61% |
| Bharat Immunologicals & Biologicals Corporation Limited | 1.88 Billion INR | 87.663% |
| Roopa Industries Limited | 647.82 Million INR | 64.074% |
| PANJON LTD. | 173.91 Million INR | -33.823% |
| Pharmaids Pharmaceuticals Limited | 913.4 Million INR | 74.52% |
| TIAAN CONSUMER LIMITED | 95.12 Million INR | -144.665% |
| Anuh Pharma Limited | 4.45 Billion INR | 94.778% |
| Crestchem Limited | 71.44 Million INR | -225.768% |
| Emmessar Biotech & Nutrition Limited | 87.42 Million INR | -166.199% |
| Sandu Pharmaceuticals Limited | 524.14 Million INR | 55.598% |
| Fredun Pharmaceuticals Limited | 3.07 Billion INR | 92.434% |
| Trimurthi Limited | 73.64 Million INR | -216.005% |
| Shukra Pharmaceuticals Limited | 778.37 Million INR | 70.1% |
| Norris Medicines Limited | 141.87 Million INR | -64.044% |
| Veerhealth Care Limited | 281.16 Million INR | 17.226% |
| Lactose (India) Limited | 1 Billion INR | 76.897% |
| OXYGENTA PHARMACEUTICAL LIMITE | 631.92 Million INR | 63.17% |
| Ambalal Sarabhai Enterprises Limited | 2.5 Billion INR | 90.699% |
| Gennex Laboratories Limited | 2.29 Billion INR | 89.88% |
| Godavari Drugs Limited | 1.34 Billion INR | 82.729% |
| Zenotech Laboratories Limited | 1.06 Billion INR | 78.087% |
| Shree Ganesh Remedies Limited | 1.7 Billion INR | 86.385% |
| Bharat Parenterals Limited | 5.03 Billion INR | 95.381% |
| Coral Laboratories Limited | 2.05 Billion INR | 88.685% |
| Evoq Remedies Limited | 368.61 Million INR | 36.861% |
| Kerala Ayurveda Limited | 1.4 Billion INR | 83.482% |
| KOBO BIOTECH LIMITED | 713.93 Million INR | 67.401% |
| Natural Capsules Limited | 3.76 Billion INR | 93.819% |
| Auro Laboratories Limited | 852.67 Million INR | 72.705% |